Publications

Publications

*Joint First Authorship

  1. Cordova, B., Milletich, P. L., Jones, M. P., McKinley, K. L., Mearig, A. J., Triplett, E. W., Ludvigsson, J. (Manuscript in Review at eBio). Microbial Functional Divergence in Infancy Precedes Irritable Bowel Syndrome Risk.

  2. Kansara, D.*, Kosikova, M.*, Milletich, P. L.*, Zhou, J., Coughlan, L., Zens, M. S., Swamy, G., Hoen, A. G., Xie, H., Ackerman, M. E., Pasetti, M. F., & DMID 09-0072 Clinical Study Group (2026). Increased dose of H1N1 pandemic influenza vaccine during pregnancy improves immunity in mothers and infants. mBio, e0390425. https://doi.org/10.1128/mbio.03904-25

  3. Shriver, M. C.*, Milletich, P. L.*, Moreno, A., Larsen, S. E., Posavad, C. M., Berube, B. J., Wali, B., Ellis, M., Manning, K., Moore, K. M., Zhu, Z., Grewal, G., Cadena, I. A., Cardemil, C. V., Munoz, F. M., Neuzil, K. M., Coler, R. N., Suthar, M. S., Pasetti, M. F., and the MOMI-Vax Study Group (2025). Development and Concordance of Binding and Neutralizing Assays to Determine SARS-CoV-2 Antibody Activity in Human Milk. Pathogens & immunity, 10(2), 97–121. https://doi.org/10.20411/pai.v10i2.799

  4. Pasetti, M. F., Milletich, P. L., White, J. A., Butts, J., Brady, R. C., Dickey, M. D., Ballou, C., Maier, N., Sztein, M. B., Baqar, S., Louis Bourgeois, A., & Bernstein, D. I. (2025). Safety and immunogenicity in humans of enterotoxigenic Escherichia coli double mutant heat-labile toxin administered intradermally. NPJ vaccines, 10(1), 23. https://doi.org/10.1038/s41541-025-01071-7

  5. Petrone, J. R., Rios Glusberger, P., George, C. D., Milletich, P. L., Ahrens, A. P., Roesch, L. F. W., & Triplett, E. W. (2023). RESCUE: a validated Nanopore pipeline to classify bacteria through long-read, 16S-ITS-23S rRNA sequencing. Frontiers in microbiology, 14, 1201064. https://doi.org/10.3389/fmicb.2023.1201064

  6. Bélteky, M.*, Milletich, P. L*., Ahrens, A. P., Triplett, E. W., & Ludvigsson, J. (2023). Infant gut microbiome composition correlated with type 1 diabetes acquisition in the general population: the ABIS study. Diabetologia, 66(6), 1116–1128. https://doi.org/10.1007/s00125-023-05895-7

  7. Berryman, M. A., Milletich, P. L., Petrone, J. R., Roesch, L. F., Ilonen, J., Triplett, E. W., & Ludvigsson, J. (2022). Autoimmune-associated genetics impact probiotic colonization of the infant gut. Journal of autoimmunity, 133, 102943. https://doi.org/10.1016/j.jaut.2022.102943

  8. Milletich, P. L., Ahrens, A. P., Russell, J. T., Petrone, J. R., Berryman, M. A., Agardh, D., Ludvigsson, J. F., Triplett, E. W., & Ludvigsson, J. (2022). Gut microbiome markers in subgroups of HLA class II genotyped infants signal future celiac disease in the general population: ABIS study. Frontiers in cellular and infection microbiology, 12, 920735. https://doi.org/10.3389/fcimb.2022.920735

Manuscripts in Progress

  1. Milletich, P. L., ElSherif, M., Marx, K., Hariri, S., Halperin, S., & Pasetti, M. F. Mucosal and Systemic Antibodies Associated with Clinical Protection in a Pertussis Controlled Human Infection Model.

  2. Milletich, P. L., Shriver, M. C., Marx, K., McGilvray, M., Flach, B., Altman, J., Ortiz, J., Ceglia, I., Krammer, F., Montefiori, D., Posavad, C. M., Schully, K. L., Roberts, P. C., & Pasetti, M.F. Refined Mucosal Sampling Methods For Accurate Analysis of Local Immunity.

  3. Dearborn, J., Frankiw, L., Limoge, D. W., Burns, C. H., Vlach, L., Milletich, P. L., Kirch, T., Miller, Z. D., Dowell, W., Languon, S., Garcia-Flores, Y., Cockrell, R. C., Baltimore, D., & Majumdar, D. Programmed Delayed Splicing: A Mechanism for Timed Inflammatory Gene Expression. 

  4. Shivnani, V., Milletich, P. L., & McCalla, S. Unraveling Infant Allergy Risk: Complementary Feeding Timing, Selection, and Gut Microbiome Axis.